Polyglycerol-Amine Covered Nanosheets Target Cell-Free DNA to Attenuate Acute Kidney Injury.
Kefei WuXiaohui LuYi LiYating WangMing LiuHongyu LiHuiyan LiQinghua LiuDan ShaoWei ChenYi ZhouZhaoxu TuHai-Ping MaoPublished in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Increased levels of circulating cell-free DNA (cfDNA) are associated with poor clinical outcomes in patients with acute kidney injury (AKI). Scavenging cfDNA by nanomaterials is regarded as a promising remedy for cfDNA-associated diseases, but a nanomaterial-based cfDNA scavenging strategy has not yet been reported for AKI treatment. Herein, polyglycerol-amine (PGA)-covered MoS 2 nanosheets with suitable size are synthesized to bind negatively charged cfDNA in vitro, in vivo and ex vivo models. The nanosheets exhibit higher cfDNA binding capacity than polymer PGA and PGA-based nanospheres owing to the flexibility and crimpability of their 2D backbone. Moreover, with low cytotoxicity and mild protein adsorption, the nanosheets effectively reduced serum cfDNA levels and predominantly accumulated in the kidneys to inhibit the formation of neutrophil extracellular traps and renal inflammation, thereby alleviating both lipopolysaccharide and ischemia-reperfusion induced AKI in mice. Further, they decreased the serum cfDNA levels in samples from AKI patients. Thus, PGA-covered MoS 2 nanosheets can serve as a potent cfDNA scavenger for treating AKI and other cfDNA-associated diseases. In addition, this work demonstrates the pivotal feature of a 2D sheet-like structure in the development of the cfDNA scavenger, which can provide a new insight into the future design of nanoplatforms for modulating inflammation.
Keyphrases
- acute kidney injury
- quantum dots
- reduced graphene oxide
- cardiac surgery
- highly efficient
- oxidative stress
- end stage renal disease
- metal organic framework
- chronic kidney disease
- transition metal
- metabolic syndrome
- type diabetes
- adipose tissue
- gold nanoparticles
- amino acid
- toll like receptor
- immune response
- protein protein
- newly diagnosed
- combination therapy
- replacement therapy
- insulin resistance